<DOC>
	<DOCNO>NCT01111097</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability oral Dichloroacetate ( DCA ) treatment recurrent malignant brain tumor ( RMBTs ) . RMBTs define either : 1 ) malignant tumor , originate brain , recur least 2 ) malignant tumor originate elsewhere body spread brain least . Otherwise , limitation number prior recurrence . There limitation number type prior therapy .</brief_summary>
	<brief_title>Study Safety Efficacy Dichloroacetate ( DCA ) Glioblastoma Other Recurrent Brain Tumors</brief_title>
	<detailed_description>Malignant brain tumor define World Health Organization grade III-IV glioma solid tumor metastasis ( spread ) brain . Recurrent malignant brain tumor ( RMBTs ) define either : 1 ) malignant tumor , originate brain , recur least 2 ) malignant tumor originate elsewhere body spread brain least . They share increase incidence , clinical radiographic characteristic , lack effective therapy , tendency recur , poor outcome . Importantly , recurrent malignant brain tumor 's share characteristic may usefully exploit emerge class biologic agent call metabolic modulators Dichloroacetate ( DCA ) drug class thoroughly investigate clinically . DCA 's mechanism action tolerability extensively demonstrate treatment chronic metabolic disorder . Furthermore , preciseness DCA 's mechanism action appear target abnormal tumor cell metabolism .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Subject must able consent self . Subject must either : 1. brain metastasis 2. WHO IIIIV glioma recur least . Females child bear age must ( ) pregnancy test . Females child bear age must use birth control study . Adequate organ function determine laboratory testing . Absence peripheral neuropathy moderate great severity ( physician determine ) . Greater 4 week time previous antineoplastic ( anticancer ) therapy . Subject must Karnofsky Performance Status ( KPS ) great equal 60 . Subject must ECOG performance status less equal 2 . There limitation number prior recurrence . There limitation number type prior therapy . Medical contraindication magnetic resonance imaging ( MRI ) testing .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Brain tumor , Glioblastoma DCA</keyword>
	<keyword>Brain tumor , Glioblastoma recurrent</keyword>
</DOC>